INR 112.2
(1.85%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 536.39 Million INR | -12.38% |
2022 | 612.2 Million INR | 20.19% |
2021 | 509.37 Million INR | -4.35% |
2020 | 532.55 Million INR | 7.12% |
2019 | 497.16 Million INR | 4.83% |
2018 | 474.24 Million INR | -6.63% |
2017 | 507.94 Million INR | -12.91% |
2016 | 583.25 Million INR | -5.9% |
2015 | 619.8 Million INR | -2.79% |
2014 | 637.6 Million INR | 40.66% |
2013 | 453.3 Million INR | 40.81% |
2012 | 321.91 Million INR | 38.85% |
2011 | 231.83 Million INR | 20.43% |
2010 | 192.5 Million INR | 21.21% |
2009 | 158.82 Million INR | 4.94% |
2008 | 151.34 Million INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 615.91 Million INR | 0.0% |
2023 Q2 | 636.59 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 FY | 536.39 Million INR | -12.38% |
2023 Q1 | - INR | -100.0% |
2023 Q4 | 536.39 Million INR | 0.0% |
2022 FY | 612.2 Million INR | 20.19% |
2022 Q4 | 612.2 Million INR | 0.0% |
2022 Q2 | 491.98 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q1 | - INR | -100.0% |
2021 Q1 | - INR | -100.0% |
2021 Q2 | 551.36 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q4 | 509.37 Million INR | 0.0% |
2021 FY | 509.37 Million INR | -4.35% |
2020 FY | 532.55 Million INR | 7.12% |
2020 Q4 | 532.55 Million INR | 0.0% |
2020 Q2 | 494.68 Million INR | 0.0% |
2019 Q2 | 498.58 Million INR | 0.0% |
2019 FY | 497.16 Million INR | 4.83% |
2019 Q4 | 497.16 Million INR | 0.0% |
2018 Q2 | 523.27 Million INR | 0.0% |
2018 Q4 | 474.24 Million INR | 0.0% |
2018 FY | 474.24 Million INR | -6.63% |
2017 Q2 | 609.29 Million INR | 0.0% |
2017 Q4 | 507.94 Million INR | 0.0% |
2017 FY | 507.94 Million INR | -12.91% |
2016 Q4 | 602.22 Million INR | 0.0% |
2016 FY | 583.25 Million INR | -5.9% |
2016 Q2 | 634.1 Million INR | 0.0% |
2015 FY | 619.8 Million INR | -2.79% |
2015 Q4 | 619.8 Million INR | 0.0% |
2015 Q2 | 633.31 Million INR | 0.0% |
2014 FY | 637.6 Million INR | 40.66% |
2014 Q4 | 637.6 Million INR | 0.0% |
2013 Q2 | 364.89 Million INR | 0.0% |
2013 FY | 453.3 Million INR | 40.81% |
2013 Q4 | 453.3 Million INR | 0.0% |
2012 FY | 321.91 Million INR | 38.85% |
2012 Q4 | 321.91 Million INR | 0.0% |
2011 FY | 231.83 Million INR | 20.43% |
2010 FY | 192.5 Million INR | 21.21% |
2009 FY | 158.82 Million INR | 4.94% |
2008 Q4 | 151.34 Million INR | 0.0% |
2008 FY | 151.34 Million INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
ANG Lifesciences India Limited | 1.66 Billion INR | 67.718% |
Add-Shop E-Retail Limited | 159.2 Million INR | -236.924% |
Bacil Pharma Limited | 1.12 Million INR | -47410.806% |
BDH Industries Limited | 312.53 Million INR | -71.628% |
Beryl Drugs Limited | 85.63 Million INR | -526.369% |
Cian Healthcare Limited | 1.03 Billion INR | 48.142% |
Chemo Pharma Laboratories Limited | 2.12 Million INR | -25106.626% |
Concord Drugs Limited | 249.88 Million INR | -114.657% |
Deccan Health Care Limited | 111.33 Million INR | -381.782% |
DECIPHER LABS LIMITED | 117.72 Million INR | -355.636% |
Gujarat Terce Laboratories Limited | 161.67 Million INR | -231.777% |
Gujarat Themis Biosyn Limited | 197.37 Million INR | -171.768% |
Hindustan Bio Sciences Limited | 25.7 Million INR | -1987.061% |
Jenburkt Pharmaceuticals Limited | 201.59 Million INR | -166.08% |
Ishita Drugs and Industries Limited | 8.87 Million INR | -5945.954% |
Kwality Pharmaceuticals Limited | 1.71 Billion INR | 68.746% |
Panchsheel Organics Limited | 340.2 Million INR | -57.67% |
KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 46.164% |
Parnax Lab Limited | 1.17 Billion INR | 54.182% |
Makers Laboratories Limited | 569.18 Million INR | 5.76% |
Medi-Caps Limited | 63.01 Million INR | -751.208% |
MedPlus Health Services Limited | 14.27 Billion INR | 96.242% |
Phaarmasia Limited | 211.49 Million INR | -153.622% |
Parmax Pharma Limited | 117.56 Million INR | -356.245% |
Patidar Buildcon Limited | 25.57 Million INR | -1997.595% |
Sanjivani Paranteral Limited. | 155.06 Million INR | -245.918% |
SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -179296.99% |
Trident Lifeline Limited | 331.26 Million INR | -61.925% |
Tyche Industries Limited | 101.64 Million INR | -427.737% |
Vivanza Biosciences Limited | 148.63 Million INR | -260.892% |
PRAVEG LIMITED | 767.53 Million INR | 30.114% |
Smruthi Organics Limited | 485.72 Million INR | -10.433% |
Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -1177.988% |
SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 68.708% |
Sastasundar Ventures Limited | 1.5 Billion INR | 64.254% |
Transchem Limited | 6.72 Million INR | -7882.098% |
Trinity League India Limited | 876 Thousand INR | -61132.534% |
Vikram Thermo (India) Limited | 291.47 Million INR | -84.028% |
Vista Pharmaceuticals Limited | 175.16 Million INR | -206.22% |
Sunil Healthcare Limited | 902.83 Million INR | 40.587% |
Syschem (India) Limited | 1.07 Billion INR | 49.903% |
Zenith Healthcare Limited | 24.03 Million INR | -2131.733% |
Zenlabs Ethica Limited | 301.35 Million INR | -77.996% |
Mercury Laboratories Limited | 171.18 Million INR | -213.336% |
SHELTER PHARMA LIMITED | 20.99 Million INR | -2455.488% |
Vasundhara Rasayans Limited | 53.64 Million INR | -899.864% |
Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 46.592% |
Roopa Industries Limited | 493.08 Million INR | -8.783% |
PANJON LTD. | 25.38 Million INR | -2013.214% |
Pharmaids Pharmaceuticals Limited | 208.44 Million INR | -157.338% |
TIAAN CONSUMER LIMITED | 14.97 Million INR | -3480.993% |
Anuh Pharma Limited | 1.54 Billion INR | 65.273% |
Crestchem Limited | 23.94 Million INR | -2139.934% |
Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -3901.47% |
Sandu Pharmaceuticals Limited | 118.22 Million INR | -353.716% |
Fredun Pharmaceuticals Limited | 1.86 Billion INR | 71.181% |
Trimurthi Limited | 101.36 Thousand INR | -529099.882% |
Shukra Pharmaceuticals Limited | 201.97 Million INR | -165.577% |
Norris Medicines Limited | 278.17 Million INR | -92.828% |
Veerhealth Care Limited | 62.78 Million INR | -754.407% |
OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 35.618% |
Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 52.569% |
Gennex Laboratories Limited | 535.21 Million INR | -0.221% |
Denis Chem Lab Limited | 289.82 Million INR | -85.078% |
Colinz Laboratories Limited | 24.1 Million INR | -2125.252% |
Godavari Drugs Limited | 957.86 Million INR | 44.001% |
Zenotech Laboratories Limited | 156.64 Million INR | -242.422% |
Shree Ganesh Remedies Limited | 488.36 Million INR | -9.835% |
Bharat Parenterals Limited | 2.65 Billion INR | 79.808% |
Coral Laboratories Limited | 281.83 Million INR | -90.32% |
Evoq Remedies Limited | 116.23 Million INR | -361.488% |
Kerala Ayurveda Limited | 1.05 Billion INR | 49.284% |
KOBO BIOTECH LIMITED | 2.04 Billion INR | 73.745% |
Natural Capsules Limited | 1.47 Billion INR | 63.688% |
Auro Laboratories Limited | 433.09 Million INR | -23.851% |